中国药品不良反应监测工作中存在的问题及对策探讨  

Problems and Countermeasures in Adverse Drug Reaction Monitoring in China

作　　者：马晓华 Ma Xiaohua(Qingyun County Market Supervision Administration,Dezhou 253700,Shandong Province,China)

机构地区：[1]庆云县市场监督管理局,山东德州253700

出　　处：《中外医药研究》2023年第15期167-168,F0003,共3页JOURNAL OF CHINESE AND FOREIGN MEDICINE AND PHARMACY RESEARCH

摘　　要：近年来,药品不良反应监测已成为提高药品安全性监管的重要组成内容,在增强规范用药水平、培养公众安全用药意识、改进上市药品安全性研究等方面有着积极意义。中国现阶段的药品不良反应监测工作尚存在一定局限,通过持续性优化不良反应监测措施,有助于及时发现药品使用的安全隐患,有效降低药品风险,为用药再评价提供数据支持。现针对中国药品不良反应监测环节中的主要问题进行探讨,提出相应的改进策略。In recent years,adverse drug reaction(ADR)monitoring has become an important component of drug safety supervi‐sion,which has positive significance in enhancing the level of standardization of drug use,cultivating public awareness of safe drug use,and improving the safety research of listed drugs.At the present stage of China's adverse drug reaction monitoring work still exists in certain limitations,through the continuous optimization of the adverse reaction monitoring measures,it helps to timely discover the safety hazards of the use of medicines,effectively reduce the risk of medicines,and provide data support for the reevaluation of drug use.The main problems in the monitoring of adverse drug reactions in China are now discussed,and corre‐sponding improvement strategies are proposed.

关 键 词：药品 不良反应 监测 对策 

分 类 号：R95[医药卫生—药学]